Health Technology Assessment Archives

Orphan drugs: overcoming HTA barriers to access

August 15, 2017

How can orphan drug manufacturers demonstrate value and improve access to drugs?

Orphan drugs: overcoming HTA barriers to access

https://pharmaphorum.com/views-and-analysis/orphan-drugs-overcoming-hta-barriers-access/

10/03/2017

Approval and access: overcoming the final hurdle of drug development

February 8, 2017

2017 is likely to be a year of significant change for pharma brands in Europe. With affordability on the agenda for

Approval and access: overcoming the final hurdle of drug development

https://pharmaphorum.com/webinars/webinars-on-demand/european-market-access-overcoming-final-hurdle-drug-development/

Fast-track appraisals and Managed Access Agreements

December 23, 2016

Experts discuss England’s proposed ‘fast-track’ appraisals for new treatments, plus MAAs.

Fast-track appraisals and Managed Access Agreements

https://pharmaphorum.com/views-and-analysis/fast-track-appraisals-managed-access-agreements/

High-value, high-cost drugs: how to pay for them

December 22, 2016

Experts call for urgent development of new drug funding mechanisms.

High-value, high-cost drugs: how to pay for them

https://pharmaphorum.com/views-and-analysis/high-value-high-cost-drugs-pay/

Who needs (early) advice? You do!

November 3, 2016

The prospects for HTA Early Scientific Advice programmes.

Who needs (early) advice? You do!

https://pharmaphorum.com/views-and-analysis/needs-early-advice/

International benchmarking and NICE

October 13, 2016

Is NICE willing to change, or is it inflexible? It is being pressed to compare itself to other HTA organisations.

International benchmarking and NICE

https://pharmaphorum.com/views-and-analysis/international-benchmarking-nice/

Trending

Health Technology Assessment

Orphan drugs: overcoming HTA barriers to access

Approval and access: overcoming the final hurdle of drug development

Fast-track appraisals and Managed Access Agreements

High-value, high-cost drugs: how to pay for them

Who needs (early) advice? You do!

International benchmarking and NICE

SMi's 12th annual Cold Chain Distribution Conference and Exhibition

RNA Therapeutics 2018

Ophthalmic Drugs - Europe's Leading Ophthalmic Conference

THET Annual Conference 2017

CRISPR & Precision Gene Editing Congress - Berlin 2017

ICI Summit Europe 2017

uniQure presses ‘refresh’ on haemophilia gene therapy, gets FDA blessing

FDA experts back Novo Nordisk’s key diabetes drug

Roche MS drug sales rise, but so does biosimilar threat

Gilead gains CAR-T approval, undercuts rival’s headline price

Lilly joins cancer vaccine race with CureVac alliance

Immigration is the Brexit bogeyman, and it’s hurting pharma already

Navigating the barriers to successful market access

Rare disease market research needs a multifaceted approach

What does your pharma brand mean to patients?

Digital health round-up: the health-tech convergence puzzle

Search

Advanced Search

Trending

Health Technology Assessment